PT  - JOURNAL ARTICLE
AU  - Hoyle, Brian
ED  - Cohen, Calvin
TI  - Noninferiority of a Single-Tablet Combination HIV-1 Regimen Reported
DP  - 2014 Dec 01
TA  - MD Conference Express
PG  - 8--9
VI  - 14
IP  - 28
4099  - http://mdc.sagepub.com/content/14/28/8.short
4100  - http://mdc.sagepub.com/content/14/28/8.full
AB  - The Single Tablet Regimen (STaR) head-to-head comparison of anti-HIV-1 formulations has established the noninferiority of rilpivirine/emtricitabine/tenofovir DF (RPV/FTC/TDF) versus efavirenz/emtricitabine/tenofovir DF (EFV/FTC/TDF) in HIV-1 virologic outcomes at weeks 48 and 96. The RPV/FTC/TDF combination was superior to EFV/FTC/TDF in terms of adverse effects and patient-reported outcomes.